An observational study in Mucormycosis, sponsored by Minia University. Completed at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2023-10-18.
Sponsored by Minia University · Observational
Detect the clinical presentation and outcome of post covid-19 fungal mucormycosis in patients referred to Minia university Hospital.
30 studies on the registry are indexed under Mucormycosis; 9 are open to participants now.
This study's enrollment of 40 is below the median of 100 across 17 observational studies indexed under Mucormycosis.
Browse Mucormycosis studies →Minia University is the lead sponsor of 356 studies on the registry; 115 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients who had fungal rhino-orbital infection and positive PCR test for Covid-19. was confirmed.
Exclusion Criteria:
Outcome of rhino-orbital mucormycosis in COVID-19 patients
Data of the patients who had post Covid-19 fungal mucormycosis in the last year will be revised to detect clinical presentation and final outcome
Time frame: 9 months
This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Minia University